IEFA - ETF AI Analysis
Top Page
iShares Core MSCI EAFE ETF (IEFA)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in the most recent month, indicating positive recent momentum.
Leading Holdings Performing Well
Several of the largest positions, including ASML, Shell, BHP, HSBC, and Commonwealth Bank of Australia, have delivered strong year-to-date results that support the fund’s overall performance.
Low Expense Ratio
The fund’s very low expense ratio helps keep costs down, allowing more of the investment returns to stay in investors’ pockets.
Negative Factors
Underperforming Defensive Giants
Some major defensive holdings like Nestlé and Roche have shown weak year-to-date performance, which can drag on the fund’s returns.
Heavy Tilt to a Few Countries
A large share of the portfolio is concentrated in Japan, the UK, France, and Germany, which increases the impact of economic or political issues in those markets.
Limited U.S. Exposure
The ETF has only a small allocation to U.S. stocks, so investors relying on it alone may miss out on parts of the U.S. market’s performance.
IEFA vs. SPDR S&P 500 ETF (SPY)
AUM186.80B
RegionDeveloped Markets
Expense Ratio0.07%
Beta0.79
IssueriShares
Inception DateOct 18, 2012
Dividend Yield3.38%
Asset ClassEquity
Index TrackedMSCI EAFE IMI
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,795,197
30 Day Avg. Volume9,853,474
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst CoveringN/A
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IEFA Summary
IEFA is the iShares Core MSCI EAFE ETF, which follows the MSCI EAFE Investable Market Index. It invests in a wide range of companies in developed countries outside North America, mainly in Europe, Japan, and Australia. The fund holds many well-known names such as Nestlé and Shell, along with banks, industrial firms, and healthcare companies. Someone might invest in IEFA to diversify beyond the U.S. and gain long-term growth from international markets in a single, low-cost fund. A key risk is that international stock prices and currencies can go up and down, affecting your investment value.
How much will it cost me?The iShares Core MSCI EAFE ETF (IEFA) has an expense ratio of 0.07%, which means you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The iShares Core MSCI EAFE ETF (IEFA) could benefit from positive trends in developed markets outside North America, such as economic recovery in Europe or technological advancements in its top holdings like ASML and SAP. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact sectors like financials and industrials, which make up a significant portion of the ETF's exposure.
IEFA Top 10 Holdings
IEFA’s story is being written largely by a handful of global heavyweights. ASML is the clear engine, with its rising share price giving the fund a strong tech tailwind, while industrial giant Siemens and resource player BHP are also pulling their weight. On the financial side, HSBC and Japan’s Mitsubishi UFJ are steadily adding support. Health care is more of a mixed bag, with Roche and AstraZeneca losing a bit of steam. Overall, the ETF leans toward developed markets in Europe and Asia, with no single stock dominating the stage.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.74% | $5.12B | €599.33B | 128.24% | 76 Outperform | |
| HSBC Holdings | 1.33% | $2.49B | £252.77B | 61.56% | 80 Outperform | |
| Roche Holding AG | 1.16% | $2.16B | $331.88B | 29.28% | 73 Outperform | |
| Novartis AG | 1.11% | $2.08B | CHF226.89B | 29.15% | 80 Outperform | |
| Nestlé SA | 1.05% | $1.96B | CHF213.91B | 4.53% | 71 Outperform | |
| AstraZeneca | 1.03% | $1.92B | $266.74B | 22.81% | 80 Outperform | |
| Siemens | 0.92% | $1.71B | €207.98B | 21.74% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 0.91% | $1.70B | ¥38.70T | 47.61% | 76 Outperform | |
| Shell (UK) | 0.91% | $1.69B | £168.62B | 13.72% | 73 Outperform | |
| BHP Group Ltd | 0.82% | $1.53B | AU$296.10B | 58.02% | 68 Neutral |
IEFA Technical Analysis
Positive
―
Price Trends
95.67
Positive
93.89
Positive
90.70
Positive
Market Momentum
0.41
Negative
54.83
Neutral
47.54
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IEFA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 96.63, equal to the 50-day MA of 95.67, and equal to the 200-day MA of 90.70, indicating a bullish trend. The MACD of 0.41 indicates Negative momentum. The RSI at 54.83 is Neutral, neither overbought nor oversold. The STOCH value of 47.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IEFA.
IEFA Peer Comparison
Comparison Results
Performance Comparison
IEFA
iShares Core MSCI EAFE ETF
96.15
15.98
19.93%
EFA
iShares MSCI EAFE ETF
―
―
―
EFV
iShares MSCI EAFE Value ETF
―
―
―
ESGD
iShares ESG Aware MSCI EAFE ETF
―
―
―
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
FENI
Fidelity Enhanced International ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents